CereScan has been awarded a three-year term of accreditation in nuclear medicine as the result of a recent review by the American College of Radiology (ACR). Nuclear medicine is a branch of medical imaging that uses safe amounts of radioactive material, to diagnose and treat a variety of diseases, including many types of cancers, heart disease, and certain other abnormalities within the body and brain.
The ACR gold seal of accreditation represents the highest level of image quality and patient safety. It is awarded only to facilities satisfying the ACR Practice Guidelines and Technical Standards after a peer-review evaluation by independent, board-certified physicians and medical physicists who are experts in the field. Image quality, personnel qualifications, adequacy of facility equipment, quality control procedures, and quality assurance programs are all assessed. The findings are reported to the ACR Committee on Accreditation, which subsequently provides the practice with a comprehensive report they can use for continuous practice improvement.
“ACR accreditation confirms the quality and validity of our Nuclear Medicine SPECT imaging procedures and will give our research partners and patients added confidence regarding our evaluations,” said Dr. Richard Fort, President & COO of CereScan.
The ACR is a national professional organization serving more than 36,000 diagnostic/interventional radiologists, radiation oncologists, nuclear medicine physicians, and medical physicists with programs focusing on the practice of medical imaging and radiation oncology and the delivery of comprehensive health care services.
CereScan is the nation’s leader in providing statistically measured brain diagnostics based on a new generation of imaging software and SPECT (Single Photon Emission Computed Tomography) neuroimaging technologies. Since 2009, patients from all over the country and throughout the world have consulted Denver-based CereScan and its leading physicians concerning chronic neurological and psychiatric issues.
Referring and treating medical experts can rely on CereScan to offer differentiated diagnoses on a wide array of brain-based disorders including:
- Traumatic Brain Injury
- Toxic Brain Injury
- Alzheimer’s Disease
- Mild Cognitive Impairment
- Other Dementias
- Parkinsonian Syndrome
- Obsessive Compulsive Disorder
- Bipolar Disorder
- Anxiety Disorder
CereScan combines state-of-the-art SPECT and PET/CT brain imaging technology with a patient centered model of care to provide the highest level of neurodiagnostics anywhere. Using quantitative functional brain imaging, advanced imaging software, and an extensive library of clinical data, the CereScan medical team provides physicians with unmatched objective diagnostic information. CereScan helps patients and their physicians better understand the biological basis of their conditions. In a variety of legal settings, CereScan provides objective evidence to attorneys and their clients regarding traumatic and toxic brain injuries. For researchers, CereScan provides independent pre- and post-treatment measures of organic changes in the brain along with measures of symptoms related to the brain disorder of interest. For more information, please call (866) 722-4806 or visit http://www.CereScan.com.